Zobrazeno 1 - 10
of 58
pro vyhledávání: '"G A Ellard"'
Autor:
C H, Withey, A O, Papacosta, A V, Swan, B A, Fitzsimons, G A, Ellard, P G, Burney, J R, Colley, W W, Holland
Publikováno v:
Journal of Epidemiology & Community Health. 46:281-285
STUDY OBJECTIVE--The aim was to investigate the effect on respiratory health of male middle tar smokers changing the tar and nicotine levels of the cigarettes they smoke for a six month period. DESIGN--This was a randomised controlled trial. Middle t
Autor:
Peter Burney, J. R. T. Colley, A V Swan, G. A. Ellard, C. H. Withey, B. A. Fitzsimons, A. O. Papacosta, Walter W. Holland
Publikováno v:
Journal of Epidemiology & Community Health. 46:274-280
STUDY OBJECTIVE--The aim was to investigate the effect on respiratory health of male middle tar smokers changing the tar and nicotine levels of the cigarettes they smoke for a six month period. DESIGN--This was a randomised controlled trial. Middle t
Autor:
G. A. Ellard
Publikováno v:
Journal of Antimicrobial Chemotherapy. 28:347-355
Growth rates and cellular levels of RNA, DNA and protein were studied in Escherichia coli during and following exposure to rifampicin, and in the transition from stationary to exponential phase growth in drug-free medium. At rifampicin concentrations
Publikováno v:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 5(8)
The perceived need for simple, non-invasive methods of assessing the relative bioavailability of rifampicin in fixed-dose combination (FDC) anti-tuberculosis formulations.To compare the performance of methods based on urinary excretion data with thos
Autor:
G A, Ellard
Publikováno v:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 3(11 Suppl 3)
The perceived need to demonstrate whether or not the actual amounts of rifampicin, isoniazid and pyrazinamide in fixed-dose combination tablets or capsules correspond to their stated drug contents.To adapt specific, robust and simple colorimetric met
Publikováno v:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 3(11 Suppl 3)
The prerequisite for in vivo bioavailability testing of rifampicin in fixed-dose combination (FDC) formulations is widely accepted. However, many smaller drug regulatory authorities and drug manufacturers have difficulty implementing costly and cumbe
Autor:
G A, Ellard, P B, Fourie
Publikováno v:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 3(11 Suppl 3)
The World Health Organization encourages the use of fixed dose combinations (FDCs) of rifampicin (RMP) and isoniazid together with pyrazinamide or pyrazinamide plus ethambutol for the treatment of tuberculosis. The main advantages of such FDCs are th
Autor:
G A, Ellard
Publikováno v:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 3(11 Suppl 3)
The perceived need to demonstrate whether or not the rifampicin bioavailability of commercially manufactured fixed-dose combinations is satisfactory.To establish an international laboratory network to assess rifampicin bioavailability.Convenient assa
Publikováno v:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 3(10 Suppl 2)
Publikováno v:
Clinical chemistry. 44(2)
The performance of a simple colorimetric assay for urinary nicotine metabolites to assess smoking status in diabetic subjects (n = 251) was investigated. Several variations of the colorimetric assay and a qualitative extraction procedure were evaluat